 | |
| Clinical data | |
|---|---|
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C26H39NO4 |
| Molar mass | 429.601 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
  (what is this?) (verify) | |
Adaprolol is a beta blocker. [1] [2]
An international nonproprietary name (INN) is an official generic and non-proprietary name given to a pharmaceutical drug or an active ingredient. INNs are intended to make communication more precise by providing a unique standard name for each active ingredient, to avoid prescribing errors. The INN system has been coordinated by the World Health Organization (WHO) since 1953.
Azapirones are a class of drugs used as anxiolytics, antidepressants, and antipsychotics. They are commonly used as add-ons to other antidepressants, such as selective serotonin reuptake inhibitors (SSRIs).
Phenacemide, also known as phenylacetylurea, is an anticonvulsant of the ureide (acetylurea) class. It is a congener and ring-opened analogue of phenytoin, and is structurally related to the barbiturates and to other hydantoins. Phenacemide was introduced in 1949 for the treatment of epilepsy, but was eventually withdrawn due to toxicity.
Febarbamate, also known as phenobamate, is an anxiolytic and tranquilizer of the barbiturate and carbamate families which is used in Europe by itself and as part of a combination drug formulation called tetrabamate.
Dimetotiazine (INN) is a phenothiazine drug used for the treatment of migraine. It is a serotonin antagonist and histamine antagonist.
Alfadolone (INN), or alphadolone is a neuroactive steroid and general anesthetic. Along with alfaxolone, as alfadolone acetate, it is one of the components of the anesthetic drug mixture althesin.
Moracizine or moricizine, sold under the trade name Ethmozine, is an antiarrhythmic of class IC. It was used for the prophylaxis and treatment of serious and life-threatening ventricular arrhythmias, but was withdrawn in 2007 for commercial reasons.
Etolorex is an anorectic of the amphetamine class. It was never marketed.
Tolgabide is a drug which was patented by Synthélabo as an anticonvulsant but was never marketed. It is an analogue of progabide and acts similarly to it as a prodrug of GABA, and therefore as an indirect agonist of the GABA receptors.
Aloracetam (INN) is a drug described as a nootropic which is closely related to, but technically not of, the racetam family of compounds. It was studied by Aventis for the treatment of Alzheimer's disease, but was never marketed.
Nisobamate is a tranquilizer of the carbamate family which was never marketed.
Lorbamate is a muscle relaxant and tranquilizer of the carbamate family which was never marketed.
Hexapradol (INN) is a psychostimulant drug which was never marketed.
Morforex, also referable to as N-morpholinoethylamphetamine, is an anorectic which was never marketed.
Picilorex is an anorectic which is no longer marketed. It is a monoamine reuptake inhibitor.
Acridorex is an amphetamine which was investigated as an anorectic but does not appear to have ever been marketed.
Oxifentorex (INN) is an amphetamine described as an anorectic which does not appear to have ever been marketed.
Fenisorex is an amphetamine-like anorectic drug which does not appear to have ever been marketed.
Metaglycodol (INN) is a drug described as a tranquilizer which was never marketed.
Furostilbestrol (INN), also known as diethylstilbestrol di(2-furoate) or simply as diesthylstilbestrol difuroate, is a synthetic, nonsteroidal estrogen of the stilbestrol group related to diethylstilbestrol that was never marketed. It is an ester of diethylstilbestrol and was described in the literature in 1952.
 | This article about an amine is a stub. You can help Wikipedia by expanding it. |
 | This antihypertensive-related article is a stub. You can help Wikipedia by expanding it. |
